• June 10, 2010
    SOCMA Member Ash Stevens Plans $20 Million Expansion (SOCMA Blog)

  • June 9, 2010
    Crain's Detroit Business Ranks Ash Stevens Fastest Growing Biotech Company in the Detroit Area

  • May 1, 2010
    Only You Can Prevent Cross-Contamination (Contract Pharma)

  • April 13, 2010
    Trends in Innovator Contract Pharmaceutical Manufacturing (Contract Pharma)

  • April 8, 2009
    Ash Stevens Inc. CEO to Chair Session on Cancer Drug Development at American Association for Cancer Research Annual Meeting

  • April 7, 2010
    Cleaning & Validation (Manufacturing Chemist)



Ash Stevens develops, registers
and manufactures Active
Pharmaceutical Ingredients.

With over 45 years of experience, an exceptional approval rate,
and an excellent global regulatory inspection history. Ash Stevens
is a world leader in the development, manufacture and registration
of small molecule APIs.

We focus on
your success.

Learn everything you need to know about API, cGMP, IND, and NDAs here.